Eisai High-dose Finibax Obtains Japanese Approval Recommendation
This article was originally published in PharmAsia News
Executive Summary
The Second Committee on New Drugs at the Ministry of Health, Labor and Welfare recommended Eisai's new broad-spectrum antibiotic Finibax (doripnem) intravenous injection for approval